Customize your JAMA Network experience by selecting one or more topics from the list below.
To the Editor We read with interest the Research Letter by Yu et al on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission in patients with cancer at a tertiary care hospital in Wuhan, China, recently published in JAMA Oncology.1 Among 1524 admitted patients with cancer, 12 (0.79%) had coronavirus disease 2019 (COVID-19). Seven of these 12 patients had lung cancer, suggesting a predilection for patients with lung cancer. Notably, only 1 of the 7 patients (14%) with lung cancer who were diagnosed with COVID-19 had a positive result on real-time reverse transcriptase polymerase chain reaction (PCR) testing. In contrast, 3 of the 5 patients (60%) with a cancer other than lung cancer had a positive PCR result. This does not reach statistical significance given the small sample size (P = .09 using the χ2 test).
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Robinson A, Gyawali B, Booth CM. Risk of COVID-19 in Patients With Cancer. JAMA Oncol. Published online July 02, 2020. doi:10.1001/jamaoncol.2020.2586
Create a personal account or sign in to: